In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of enterobacteriaceae
- 30 September 1993
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 17 (2) , 171-175
- https://doi.org/10.1016/0732-8893(93)90030-b
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1986
- Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamasesAntimicrobial Agents and Chemotherapy, 1986
- Plasmid-determined β-lactamases identified in a group of 204 ampicillin-resistant EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 1983
- Clavulanic acid and CP-45, 899: a comparison of their in vitro activity in combination with penicillinsJournal of Antimicrobial Chemotherapy, 1980
- Comparative Inhibition of β-Lactamases by Novel β-Lactam CompoundsAntimicrobial Agents and Chemotherapy, 1979
- CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological CharacterizationAntimicrobial Agents and Chemotherapy, 1978
- Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerusAntimicrobial Agents and Chemotherapy, 1977
- Comparative Clinical Pharmacology of Amoxicillin and Ampicillin Administered OrallyAntimicrobial Agents and Chemotherapy, 1972